ArticleJournal of health, population, and nutrition2019
Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitus.
Junichi Okada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.